MoonLake Immunotherapeutics - Ordinary Shares - Class A
XNAS: MLTX
MoonLake Immunotherapeutics - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart
about
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibit...
Read More
50.46
-1.89
(-3.61%)
1.2M
XNAS Volume
High volume today
XNAS 30 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for MoonLake Immunotherapeutics - Ordinary Shares - Class A is on 07 Aug 2025 for the purpose of MoonLake Immunotherapeutics Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
MoonLake Immunotherapeutic... Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..